AIG
IRWD icon

American International Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

American International Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-74,691
Closed -$651K – 1338
2024
Q1 		$651K Sell
74,691
-666
-0.9% -$8.08K ﹤0.01% 1523
2023
Q4 		$862K Sell
75,357
-624
-0.8% -$6.17K ﹤0.01% 1384
2023
Q3 		$732K Buy
75,981
+1,743
+2% +$17.1K ﹤0.01% 1391
2023
Q2 		$790K Sell
74,238
-175
-0.2% -$1.88K ﹤0.01% 1370
2023
Q1 		$783K Buy
74,413
+355
+0.5% +$3.98K 0.01% 1347
2022
Q4 		$918K Sell
74,058
-566
-0.8% -$6.42K 0.01% 1254
2022
Q3 		$773K Sell
74,624
-695
-0.9% -$7.88K 0.01% 1313
2022
Q2 		$868K Buy
75,319
+2,441
+3% +$28.8K 0.01% 1269
2022
Q1 		$917K Sell
72,878
-5,129
-7% -$58.8K 0.01% 1388
2021
Q4 		$910K Sell
78,007
-1,508
-2% -$18.5K ﹤0.01% 1478
2021
Q3 		$1.04M Sell
79,515
-1,889
-2% -$24.4K 0.01% 1431
2021
Q2 		$1.05K Sell
81,404
-41,569
-34% -$476K ﹤0.01% 1488
2021
Q1 		$1.38K Sell
122,973
-3,731
-3% -$39.4K ﹤0.01% 1304
2020
Q4 		$1.44K Buy
126,704
+31,282
+33% +$342K 0.01% 1221
2020
Q3 		$858K Sell
95,422
-2,170
-2% -$21.6K ﹤0.01% 1319
2020
Q2 		$1.01M Buy
97,592
+5,101
+6% +$52.2K ﹤0.01% 1221
2020
Q1 		$933K Sell
92,491
-3,746
-4% -$44K 0.01% 1141
2019
Q4 		$1.28M Sell
96,237
-809
-0.8% -$8.92K ﹤0.01% 1204
2019
Q3 		$833K Sell
97,046
-677
-0.7% -$6.58K ﹤0.01% 1392
2019
Q2 		$1.07M Sell
97,723
-9,391
-9% -$105K ﹤0.01% 1281
2019
Q1 		$1.21M Sell
107,114
-3,472
-3% -$38.8K ﹤0.01% 1217
2018
Q4 		$960K Buy
110,586
+850
+0.8% +$9.76K ﹤0.01% 1290
2018
Q3 		$1.7M Buy
109,736
+1,977
+2% +$31.3K 0.01% 1129
2018
Q2 		$1.73M Buy
107,759
+4,968
+5% +$73.5K 0.01% 1075
2018
Q1 		$1.33M Sell
102,791
-5,530
-5% -$68.9K ﹤0.01% 1119
2017
Q4 		$1.36M Buy
108,321
+514
+0.5% +$6.71K ﹤0.01% 1182
2017
Q3 		$1.42M Buy
107,807
+8,060
+8% +$111K 0.01% 1139
2017
Q2 		$1.58M Buy
99,747
+6,202
+7% +$90.1K 0.01% 1053
2017
Q1 		$1.34M Buy
93,545
+4,704
+5% +$64.3K ﹤0.01% 1077
2016
Q4 		$1.14M Sell
88,841
-229
-0.3% -$2.89K ﹤0.01% 1170
2016
Q3 		$1.18M Buy
89,070
+136
+0.2% +$1.59K ﹤0.01% 1116
2016
Q2 		$974K Buy
88,934
+862
+1% +$8.42K ﹤0.01% 1194
2016
Q1 		$807K Hold
88,072
– – ﹤0.01% 1631
2015
Q4 		$855K Sell
88,072
-153
-0.2% -$1.48K ﹤0.01% 1599
2015
Q3 		$770K Buy
88,225
+105
+0.1% +$980 ﹤0.01% 1642
2015
Q2 		$890K Sell
88,120
-1,596
-2% -$18.6K ﹤0.01% 1678
2015
Q1 		$1.2M Hold
89,716
– – 0.01% 1479
2014
Q4 		$1.15M Sell
89,716
-5,323
-6% -$60.9K 0.01% 1463
2014
Q3 		$1.03M Buy
95,039
+1,704
+2% +$19.5K ﹤0.01% 1552
2014
Q2 		$1.2M Buy
93,335
+7,590
+9% +$82.5K 0.01% 1446
2014
Q1 		$885K Buy
85,745
+12,011
+16% +$135K ﹤0.01% 1630
2013
Q4 		$717K Sell
73,734
-741
-1% -$6.65K ﹤0.01% 1741
2013
Q3 		$739K Buy
74,475
+5,087
+7% +$49.9K ﹤0.01% 1658
2013
Q2 		$578K Buy
+69,388
New +$841K ﹤0.01% 1753

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

American International Group's IRWD Position: Q2 2024 in Review

American International Group sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 74,691 shares — an estimated $651K sold.

American International Group first reported a position in IRWD in Q2 2013 and held it in 44 quarters. The position peaked at $1.73M in Q2 2018. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • American International Group reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 74,691 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $651K.
  • American International Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 44 quarters.
  • American International Group's Ironwood Pharmaceuticals position peaked at $1.73M in Q2 2018.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.